New data show midkine expression is heightened in small cell lung cancer, suggesting the growth factor may be an important ...

Artificial Intelligence is being utilized to engineer custom proteins that enhance the ability of immune cells to locate and eradicate cancer cells effectively.

David Baker’s Nobel Prize-winning lab has generated AI-designed proteins to enhance the immune system's ability to detect and ...

A new study has found that patients with metastatic non–small cell lung cancer and pre-existing rheumatoid arthritis have similar overall survival to those without RA when treated with immune ...

A virus that typically infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy—and researchers are uncovering ...

Some lung cancers do not respond well to immunotherapy, a treatment that helps the body’s immune system attack cancer. But a new study shows that radiation therapy might help solve this problem. The ...

Weill Cancer Hub West will harness genomics, big data, AI, and machine learning to counter California’s 20 new cancer cases ...

Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope ...

Fotivda preserved quality-of-life scores in kidney cancer, with better outcomes in second-line use and no added benefit from combining with Opdivo.

During a live event, Bruna Pellini, MD, discussed the efficacy of cemiplimab in PD-L1-high non–small cell lung cancer.

Precision cancer treatment on a larger scale is moving closer now that researchers have developed an AI platform to tailor ...

Cancer cells and tumors do not exist in a vacuum. Far from the isolation and self-sufficiency of the fictional Wakanda, tumors develop in and alter the nearby milieu of immune cells, connective tissue ...